# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 03-29-2024 | 12-31-2023 | 10-K | |
2 | 11-14-2023 | 09-30-2023 | 10-Q | |
3 | 08-29-2023 | 06-30-2023 | 10-Q |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...